Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Human Papillomavirus: From Basic Science to Clinical Management for Preclinical Medical Students.

Wiley R, Shelal Z, Bernard C, Urbauer D, Toy E, Ramondetta L.

MedEdPORTAL. 2018 Dec 21;14:10787. doi: 10.15766/mep_2374-8265.10787.

2.
3.

Perceptions of Missed Care Across Oncology Nursing Specialty Units.

Villamin C, Anderson J, Fellman B, Urbauer D, Brassil K.

J Nurs Care Qual. 2019 Jan/Mar;34(1):47-53. doi: 10.1097/NCQ.0000000000000324.

PMID:
30475323
4.

A snapshot of medical physics practice patterns.

Kisling KD, Ger RB, Netherton TJ, Cardenas CE, Owens CA, Anderson BM, Lee J, Rhee DJ, Edward SS, Gay SS, He Y, David SD, Yang J, Nitsch PL, Balter PA, Urbauer DL, Peterson CB, Court LE, Dube S.

J Appl Clin Med Phys. 2018 Nov;19(6):306-315. doi: 10.1002/acm2.12464. Epub 2018 Oct 1.

5.

Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.

Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD.

BMC Cancer. 2018 Sep 19;18(1):903. doi: 10.1186/s12885-018-4808-5.

6.

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.

Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, Gien LT, Urbauer DL, Abu-Rustum NR.

Lancet Oncol. 2018 Oct;19(10):1394-1403. doi: 10.1016/S1470-2045(18)30448-0. Epub 2018 Aug 22.

PMID:
30143441
7.

Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.

Yates MS, Coletta AM, Zhang Q, Schmandt RE, Medepalli M, Nebgen D, Soletsky B, Milbourne A, Levy E, Fellman B, Urbauer D, Yuan Y, Broaddus RR, Basen-Engquist K, Lu K.

Cancer Prev Res (Phila). 2018 Aug;11(8):477-490. doi: 10.1158/1940-6207.CAPR-17-0398. Epub 2018 May 1.

PMID:
29716897
8.

Variations in Missed Care Across Oncology Nursing Specialty Units.

Villamin C, Anderson J, Fellman B, Urbauer D, Brassil K.

J Nurs Care Qual. 2018 Apr 19. doi: 10.1097/NCQ.0000000000000324. [Epub ahead of print]

PMID:
29677025
9.

Team-Based Learning Module for Undergraduate Medical Education: a Module Focused on the Human Papilloma Virus to Increase Willingness to Vaccinate.

Wiley R, Shelal Z, Bernard C, Urbauer D, Toy E, Ramondetta L.

J Cancer Educ. 2019 Apr;34(2):357-362. doi: 10.1007/s13187-017-1311-7.

PMID:
29280059
10.

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.

Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN.

Obstet Gynecol. 2018 Jan;131(1):109-116. doi: 10.1097/AOG.0000000000002390.

11.

Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications.

Jones D, Cohen L, Rieber AG, Urbauer D, Fellman B, Fisch MJ, Nazario A.

Integr Cancer Ther. 2018 Jun;17(2):371-379. doi: 10.1177/1534735417735892. Epub 2017 Oct 13.

12.

Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.

Kawakami F, Sircar K, Rodriguez-Canales J, Fellman BM, Urbauer DL, Tamboli P, Tannir NM, Jonasch E, Wistuba II, Wood CG, Karam JA.

Cancer. 2017 Dec 15;123(24):4823-4831. doi: 10.1002/cncr.30937. Epub 2017 Aug 22.

13.

The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma.

Chéry L, Borregales LD, Fellman B, Urbauer DL, Garg N, Parker N, Katz MHG, Wood CG, Karam JA.

Urology. 2017 Oct;108:114-121. doi: 10.1016/j.urology.2017.05.056. Epub 2017 Jul 10.

14.

The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients.

Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DC.

Int J Gynecol Cancer. 2017 May;27(4):838-846. doi: 10.1097/IGC.0000000000000953.

15.

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.

Kurnit KC, Kim GN, Fellman BM, Urbauer DL, Mills GB, Zhang W, Broaddus RR.

Mod Pathol. 2017 Jul;30(7):1032-1041. doi: 10.1038/modpathol.2017.15. Epub 2017 Mar 10.

16.

Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients.

Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM.

Support Care Cancer. 2017 Jun;25(6):1985-1991. doi: 10.1007/s00520-017-3605-z. Epub 2017 Feb 7.

17.

Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.

Bruegl AS, Ring KL, Daniels M, Fellman BM, Urbauer DL, Broaddus RR.

Cancer Prev Res (Phila). 2017 Feb;10(2):108-115. doi: 10.1158/1940-6207.CAPR-16-0219. Epub 2016 Dec 13.

18.

Effect of routine screening for sexual problems in a breast cancer survivorship clinic.

Bradford A, Fellman B, Urbauer D, Bevers T.

Psychooncology. 2016 Nov;25(11):1375-1378. doi: 10.1002/pon.3999. Epub 2015 Oct 9. No abstract available.

19.

Do No Harm, Except to Ourselves? A Survey of Symptoms and Injuries in Oncologic Surgeons and Pilot Study of an Intraoperative Ergonomic Intervention.

Voss RK, Chiang YJ, Cromwell KD, Urbauer DL, Lee JE, Cormier JN, Stucky CH.

J Am Coll Surg. 2017 Jan;224(1):16-25.e1. doi: 10.1016/j.jamcollsurg.2016.09.013. Epub 2016 Sep 30.

PMID:
27693681
20.

Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients.

Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka DC.

Gynecol Oncol. 2016 Sep;142(3):525-30. doi: 10.1016/j.ygyno.2016.07.010. Epub 2016 Jul 18.

21.

Endometrial Cancer Associated Symptoms: A Case-Control Study.

Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PT.

J Womens Health (Larchmt). 2016 Nov;25(11):1187-1192. Epub 2016 Jun 2.

22.

Nurse and patient characteristics predict communication about complementary and alternative medicine.

Spencer CN, Lopez G, Cohen L, Urbauer DL, Hallman DM, Fisch MJ, Parker PA.

Cancer. 2016 May 15;122(10):1552-9. doi: 10.1002/cncr.29819. Epub 2016 Mar 17.

23.

Depression and Oropharynx Cancer Outcome.

Shinn EH, Valentine A, Jethanandani A, Basen-Engquist K, Fellman B, Urbauer D, Atkinson E, Yusuf SW, Lenihan D, Woods ML, Kies MS, Sood AK, Carmack C, Morrison WH, Gillenwater A, Sturgis EM, Garden AS.

Psychosom Med. 2016 Jan;78(1):38-48. doi: 10.1097/PSY.0000000000000256.

24.

Erythropoietin Stimulates Tumor Growth via EphB4.

Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, Nagaraja AS, Previs RA, Vivas-Mejia P, Han HD, Hu W, Mangala LS, Zand B, Stagg LJ, Ladbury JE, Ozpolat B, Alpay SN, Nishimura M, Stone RL, Matsuo K, Armaiz-Peña GN, Dalton HJ, Danes C, Goodman B, Rodriguez-Aguayo C, Kruger C, Schneider A, Haghpeykar S, Jaladurgam P, Hung MC, Coleman RL, Liu J, Li C, Urbauer D, Lopez-Berestein G, Jackson DB, Sood AK.

Cancer Cell. 2015 Nov 9;28(5):610-622. doi: 10.1016/j.ccell.2015.09.008. Epub 2015 Oct 17.

25.

Reply to beta blockers in epithelial ovarian cancer and beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

Thaker PH, Urbauer DL, Sood AK.

Cancer. 2016 Jan 15;122(2):325-6. doi: 10.1002/cncr.29723. Epub 2015 Oct 7. No abstract available.

26.

Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers.

Bradford A, Fellman B, Urbauer D, Gallegos J, Meaders K, Tung C, Ramondetta L.

Gynecol Oncol. 2015 Oct;139(1):134-40. doi: 10.1016/j.ygyno.2015.08.019. Epub 2015 Aug 29.

27.

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.

Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK.

Cancer. 2015 Oct 1;121(19):3444-51. doi: 10.1002/cncr.29392. Epub 2015 Aug 24.

29.

Survivors of gynecologic malignancies: impact of treatment on health and well-being.

Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC.

J Cancer Surviv. 2016 Apr;10(2):261-70. doi: 10.1007/s11764-015-0472-9. Epub 2015 Aug 6.

30.

Is it equivalent? Evaluation of the clinical activity of single agent Lipodox® compared to single agent Doxil® in ovarian cancer treatment.

Smith JA, Costales AB, Jaffari M, Urbauer DL, Frumovitz M, Kutac CK, Tran H, Coleman RL.

J Oncol Pharm Pract. 2016 Aug;22(4):599-604. doi: 10.1177/1078155215594415. Epub 2015 Jul 15.

PMID:
26183293
31.

Intact PTEN Expression by Immunohistochemistry is Associated With Decreased Survival in Advanced Stage Ovarian/Primary Peritoneal High-grade Serous Carcinoma.

Bakkar RM, Xie SS, Urbauer DL, Djordjevic B, Vu K, Broaddus RR.

Int J Gynecol Pathol. 2015 Nov;34(6):497-506. doi: 10.1097/PGP.0000000000000205.

PMID:
26166715
32.

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin.

Kamat AM, Briggman J, Urbauer DL, Svatek R, Nogueras González GM, Anderson R, Grossman HB, Prat F, Dinney CP.

Eur Urol. 2016 Feb;69(2):197-200. doi: 10.1016/j.eururo.2015.06.023. Epub 2015 Jun 25. Erratum in: Eur Urol. 2016 Jul;70(1):e26.

33.

Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.

Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, Matin SF, Wood CG, Karam JA.

BJU Int. 2016 May;117(5):775-82. doi: 10.1111/bju.13194. Epub 2015 Jul 5.

34.

Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial.

Karam JA, Devine CE, Fellman BM, Urbauer DL, Abel EJ, Allaf ME, Bex A, Lane BR, Thompson RH, Wood CG.

BJU Int. 2016 Apr;117(4):629-35. doi: 10.1111/bju.13188. Epub 2015 Jun 29.

35.

Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.

Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LM.

Gynecol Oncol. 2015 Aug;138(2):388-93. doi: 10.1016/j.ygyno.2015.05.005. Epub 2015 May 16.

PMID:
25988961
36.

Targeting those with decreased meaning and peace: a supportive care opportunity.

Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM.

Support Care Cancer. 2015 Jul;23(7):2025-32. doi: 10.1007/s00520-014-2568-6. Epub 2014 Dec 18.

37.

Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors.

Dempsey KM, Broaddus R, You YN, Noblin SJ, Mork M, Fellman B, Urbauer D, Daniels M, Lu K.

Genet Med. 2015 Jun;17(6):476-84. doi: 10.1038/gim.2014.131. Epub 2014 Oct 23.

38.

Overall survival after pelvic exenteration for gynecologic malignancy.

Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Sep;134(3):546-51. doi: 10.1016/j.ygyno.2014.06.034. Epub 2014 Jul 9.

39.

Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun C, Lu KH, Broaddus RR.

Cancer Prev Res (Phila). 2014 Jul;7(7):686-97. doi: 10.1158/1940-6207.CAPR-13-0359. Epub 2014 Apr 25.

40.

CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.

Zhang Q, Schmandt R, Celestino J, McCampbell A, Yates MS, Urbauer DL, Broaddus RR, Loose DS, Shipley GL, Lu KH.

Gynecol Oncol. 2014 Apr;133(1):83-9. doi: 10.1016/j.ygyno.2013.12.006.

41.

Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.

Daniels MS, Babb SA, King RH, Urbauer DL, Batte BA, Brandt AC, Amos CI, Buchanan AH, Mutch DG, Lu KH.

J Clin Oncol. 2014 Apr 20;32(12):1249-55. doi: 10.1200/JCO.2013.50.6055. Epub 2014 Mar 17.

42.

Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.

Karam JA, Devine CE, Urbauer DL, Lozano M, Maity T, Ahrar K, Tamboli P, Tannir NM, Wood CG.

Eur Urol. 2014 Nov;66(5):874-80. doi: 10.1016/j.eururo.2014.01.035. Epub 2014 Feb 7.

43.

Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.

Huang J, Hu W, Bottsford-Miller J, Liu T, Han HD, Zand B, Pradeep S, Roh JW, Thanapprapasr D, Dalton HJ, Pecot CV, Rupaimoole R, Lu C, Fellman B, Urbauer D, Kang Y, Jennings NB, Huang L, Deavers MT, Broaddus R, Coleman RL, Sood AK.

Clin Cancer Res. 2014 Apr 1;20(7):1846-55. doi: 10.1158/1078-0432.CCR-13-2141. Epub 2014 Jan 31.

44.

Pelvic exenteration: impact of age on surgical and oncologic outcomes.

Huang M, Iglesias DA, Westin SN, Fellman B, Urbauer D, Schmeler KM, Frumovitz M, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Jan;132(1):114-8. doi: 10.1016/j.ygyno.2013.11.014. Epub 2013 Nov 18.

45.

Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist.

Daniels MS, Urbauer DL, Zangeneh A, Batte BA, Dempsey KM, Lu KH.

Gynecol Oncol. 2013 Dec;131(3):619-23. doi: 10.1016/j.ygyno.2013.10.011. Epub 2013 Oct 17.

46.

Randomized controlled trial of a sun protection intervention for children of melanoma survivors.

Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Urbauer DL, Fellman BM, Lee JE, Gershenwald JE.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1813-24. doi: 10.1158/1055-9965.EPI-13-0249.

47.

Impact of an incentive-based mobility program, "Motivated and Moving," on physiologic and quality of life outcomes in a stem cell transplant population.

Brassil KJ, Szewczyk N, Fellman B, Neumann J, Burgess J, Urbauer D, LoBiondo-Wood G.

Cancer Nurs. 2014 Sep-Oct;37(5):345-54. doi: 10.1097/NCC.0b013e3182a40db2.

PMID:
24067357
48.

Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review.

Hoang AN, Agarwal PK, Walton-Diaz A, Wood CG, Metwalli AR, Kassouf W, Brown GA, Black PC, Urbauer DL, Grossman HB, Dinney CP, Kamat AM.

BJU Int. 2014 May;113(5b):E28-33. doi: 10.1111/bju.12344. Review.

49.

Impact of cardiovascular comorbidity on ovarian cancer mortality.

Shinn EH, Lenihan DJ, Urbauer DL, Basen-Engquist KM, Valentine A, Palmero L, Woods ML, Patel P, Nick AM, Shahzad MM, Stone RL, Golden A, Atkinson E, Lutgendorf SK, Sood AK.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2102-9. doi: 10.1158/1055-9965.EPI-13-0625. Epub 2013 Sep 17.

50.

Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer.

Bruegl AS, Djordjevic B, Urbauer DL, Westin SN, Soliman PT, Lu KH, Luthra R, Broaddus RR.

Curr Pharm Des. 2014;20(11):1655-63.

Supplemental Content

Loading ...
Support Center